Skip to content. | Skip to navigation

Garvan Institute

Sections
 

Greenfield

 

In collaboration with the James group, we are undertaking a major study to identify defects in insulin signal transduction in skeletal muscle from at-risk individuals. We are also examining the possible role of the autonomic nervous system in the development of diabetes and obesity. Studies have also been established examining the effects of glutamine, an amino acid, on metabolism, both in isolation and in combination with a new diabetes medication. Glutamine appears to have a promising effect on glucose lowering in the post-meal state and may offer a simple, novel and effective treatment in type 2 diabetes.

Click here to view details of our Metabolism Study (screening for a gene that links to obesity). We are currently recruiting volunteers to participate.

 

Staff

 

Dr Katherine TonksClinical Research Officer
Dr Katherine Tonks
Olivia WongClinical Research Nurse
Olivia Wong
Vanessa Travers2Clinical Research Nurse
Vanessa Travers
Renee RichensClinical Research Nurse
Renee Richens
Daniel ChenPostgraduate Scholar
Dr Daniel Chen
Tanya ThompsonResearch Assistant
Tanya Thompson
Vita BirznieceResearch Fellow
Dr Vita Birzniece
Surya SutantoResearch Assistant
Surya Sutanto
Ann McCormackVisiting Scientist
Dr Ann McCormack


 

 

See also:

Chisholm Research Group

Samaras Research Group

Campbell Research Group

James Research Group

News

 

Understanding why some obese people stay sensitive to insulin

MEDIA RELEASE: 01 Feb 2012
Obesity, especially central obesity, is associated with insulin resistance, which precedes diabetes, sometimes by more than a decade. However, it’s not only a question of body weight or fat distribution, because some obese people remain insulin-sensitive, with insulin working as well in their bodies as in someone lean.
 
 

Personal tools